| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |